MTOR and hepatocellular carcinoma: The novel PI3K/mTOR inhibitors, GDC-0980, GDC-0941 and PF-04691502 have been reported to induce G1 cell-cycle arrest in breast, lung, glioblastoma and hepatocellular carcinoma cells [27, 41–43].